EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Single-cell RNA sequencing: enhancing the predictive accuracy of tumor immunotherapy efficacy

Wei Zhou iD, Ziwei Huang, Zhiyun Wu, Mengyuan Tang, Linqi Zhu, Weifeng Shi, Qi Wang iD, Liangzhu Feng iD

Essays in Biochemistry · 2025

DOI: 10.1042/ebc20253017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Essays in Biochemistry, 2025. Verfasst von Wei Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Third Affiliated Hospital of Soochow University, ChangZhou, Jiangsu, 213003, China. Hauptthemen laut MEDLINE: Immunotherapy, Single-Cell Analysis, Neoplasms, Sequence Analysis, RNA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The swift advancement of single-cell RNA sequencing (scRNA-seq) technology has furnished a crucial instrument for investigating the tumor microenvironment (TME) and its response to immunotherapy. As immunotherapy becomes increasingly prevalent, the challenge of accurately predicting its efficacy has emerged as a prominent focus in contemporary research. In recent years, the utilization of scRNA-seq in the context of immunotherapy has demonstrated promising potential, particularly in the realms of efficacy prediction and biomarker discovery. The heterogeneity of immune cells within the TME exerts intricate and multifaceted influences on treatment response, necessitating comprehensive investigation. Furthermore, the integration of biomaterials into tumor immunotherapy presents novel research opportunities in this domain. scRNA-seq technology offers a systematic approach to evaluating the modifications in the TME induced by biomaterials. This article aims to review the current state of scRNA-seq in the context of immunotherapy, identify existing challenges within related research, and propose future research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapySingle-Cell AnalysisNeoplasmsSequence Analysis, RNAHumansTumor MicroenvironmentAnimalsBiomarkers, Tumor

Stichwörter der Autor:innen

biomaterialsimmune checkpoint blockade therapyimmunotherapysingle-cell RNA sequencingtumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Third Affiliated Hospital of Soochow University, ChangZhou, Jiangsu, 213003, China.
  • Department of Biological Treatment, The Third Affiliated Hospital of Soochow University, ChangZhou, Jiangsu, 213003, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, Jiangsu, 215123, China.

ORCID-Profile: Wei Zhou, Qi Wang, Liangzhu Feng

Zitieren

APA

Zhou, W., Huang, Z., Wu, Z., Tang, M., Zhu, L., Shi, W., Wang, Q., & Feng, L. (2025). Single-cell RNA sequencing: enhancing the predictive accuracy of tumor immunotherapy efficacy. Essays in Biochemistry. https://doi.org/10.1042/ebc20253017

Vancouver

Zhou W, Huang Z, Wu Z, Tang M, Zhu L, Shi W, et al. Single-cell RNA sequencing: enhancing the predictive accuracy of tumor immunotherapy efficacy. Essays in Biochemistry. 2025. doi:10.1042/ebc20253017

BibTeX
@article{Zhou2025,
  author = {Zhou, Wei and Huang, Ziwei and Wu, Zhiyun and Tang, Mengyuan and Zhu, Linqi and Shi, Weifeng and Wang, Qi and Feng, Liangzhu},
  title = {Single-cell RNA sequencing: enhancing the predictive accuracy of tumor immunotherapy efficacy},
  journal = {Essays in Biochemistry},
  year = {2025},
  doi = {10.1042/ebc20253017}
}
Kostenlos starten →